U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 26601

1.
No disease left behind
Muzamil Arshad, Connor Lynch, Rohan R. Katipally, Sean P. Pitroda, Ralph R. Weichselbaum
Oncotarget. 2025; 16: 163–166. Published online 2025 Mar 13. doi: 10.18632/oncotarget.28700
PMCID:
PMC11906142
ArticlePDF–503K
2.
EXPOSOMES and GENES: The duo influencing CANCER initiation and progression
Uzma Saqib, Katherine E. Ricks, Alexander G. Obukhov, Krishnan Hajela
Oncotarget. 2025; 16: 133–135. Published online 2025 Mar 10. doi: 10.18632/oncotarget.28696
PMCID:
PMC11893072
ArticlePDF–492K
3.
Retraction: FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
Zhongming Huang, Junhua Li, Shaohua Du, Yanghua Tang, Ligang Huang, Luwei Xiao, Peijian Tong
Oncotarget. 2025; 16: 131. Published online 2025 Feb 28. doi: 10.18632/oncotarget.28697
Retracts:
Oncotarget. 2016 Jun 28; 7(26): 39872–39884.
PMCID:
PMC11870124
RetractionPDF–215K
4.
Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters’ model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane
Ana Chor, Hélio dos Santos Dutra, Marcos Lopes Dias, Raquel Pires Gonçalves, Christina Maeda Takiya, Alexandre Malta Rossi, Marcos Farina
Oncotarget. 2025; 16: 103–117. Published online 2025 Feb 18. doi: 10.18632/oncotarget.28685
PMCID:
PMC11837862
ArticlePDF–4.7M
5.
Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
Zhikui Liu, Changwei Dou, Bowen Yao, Meng Xu, Linglong Ding, Yufeng Wang, Yuli Jia, Qing Li, Hongyong Zhang, Kangsheng Tu, Tao Song, Qingguang Liu
Oncotarget. 2025; 16: 102. Published online 2025 Feb 18. doi: 10.18632/oncotarget.28695
Retracts:
Oncotarget. 2016 May 3; 7(18): 25350–25365.
PMCID:
PMC11837860
RetractionPDF–217K
6.
Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen
Doaa A. Gamal, Aiat Morsy, Mervat Omar
Oncotarget. 2025; 16: 67–78. Published online 2025 Feb 12. doi: 10.18632/oncotarget.28687
PMCID:
PMC11823472
ArticlePDF–1.2M
7.
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
Haolong Li, Ning Xie, Martin E. Gleave, Xuesen Dong
Oncotarget. 2025; 16: 63–64. Published online 2025 Feb 12. doi: 10.18632/oncotarget.28692
Corrects:
Oncotarget. 2015 Aug 21; 6(24): 20474–20484.
PMCID:
PMC11823470
CorrectionPDF–1.2M
8.
A case report of donor cell–derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation
Aleksandra Mroczkowska-Bękarciak, Tomasz Wróbel
Oncotarget. 2025; 16: 44–50. Published online 2025 Feb 5. doi: 10.18632/oncotarget.28686
PMCID:
PMC11798483
ArticlePDF–541K
9.
Retraction: MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression
Zhe Cheng, Ling-Ling Dai, Xi Wang, Liu-Qun Jia, Xiao-Gang Jing, Peng-Fei Li, Meng Liu, Huan Wang, Lin An
Oncotarget. 2025; 16: 43. Published online 2025 Feb 5. doi: 10.18632/oncotarget.28689
Retracts:
Oncotarget. 2017 Jul 11; 8(28): 46312–46325.
PMCID:
PMC11798481
RetractionPDF–248K
10.
Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report
Jenny L. Wu, Wade T. Iams
Oncotarget. 2025; 16: 39–42. Published online 2025 Feb 5. doi: 10.18632/oncotarget.28682
PMCID:
PMC11798477
ArticlePDF–663K
11.
Assessment of cfDNA release dynamics during colorectal cancer surgery
Mailson Alves Lopes, Maria Elvira Ribeiro Cordeiro, Flávio de Alencar Teles Barreto, Lara de Souza Moreno, André Araújo de Medeiros Silva, Mariana Braccialli de Loyola, Mayra Veloso Ayrimoraes Soares, Joao Batista de Sousa, Fabio Pittella-Silva
Oncotarget. 2025; 16: 29–38. Published online 2025 Jan 21. doi: 10.18632/oncotarget.28681
PMCID:
PMC11749015
ArticlePDF–2.5M
12.
Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells
Steven A. Greenberg
Oncotarget. 2025; 16: 1–8. Published online 2025 Jan 20. doi: 10.18632/oncotarget.28679
PMCID:
PMC11745485
ArticlePDF–3.2M
13.
Retraction: Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model
Bo Zhang, Dan Wang, Tie-Feng Ji, Lei Shi, Jin-Lu Yu
Oncotarget. 2025; 16: 9. Published online 2025 Jan 20. doi: 10.18632/oncotarget.28572
Retracts:
Oncotarget. 2017 Mar 7; 8(10): 17347–17359.
PMCID:
PMC11745482
RetractionPDF–257K
14.
Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells
Zhihong Zhao, Jue Hu, Xiaoping Gao, Hui Liang, Haiya Yu, Suosi Liu, Zhan Liu
Oncotarget. 2024; 15: 806. Published online 2024 Nov 22. doi: 10.18632/oncotarget.28675
Retracts:
Oncotarget. 2017 May 2; 8(18): 30030–30038.
PMCID:
PMC11584033
RetractionPDF–218K
15.
Computed tomography-based radiomics and body composition model for predicting hepatic decompensation
Yashbir Singh, John E. Eaton, Sudhakar K. Venkatesh, Bradley J. Erickson
Oncotarget. 2024; 15: 809–813. Published online 2024 Nov 22. doi: 10.18632/oncotarget.28673
PMCID:
PMC11584029
ArticlePDF–628K
16.
Visualizing radiological data bias through persistence images
Yashbir Singh, Colleen Farrelly, Quincy A. Hathaway, Gunnar Carlsson
Oncotarget. 2024; 15: 787–789. Published online 2024 Nov 12. doi: 10.18632/oncotarget.28670
PMCID:
PMC11559657
ArticlePDF–263K
17.
Persistence landscapes: Charting a path to unbiased radiological interpretation
Yashbir Singh, Colleen Farrelly, Quincy A. Hathaway, Gunnar Carlsson
Oncotarget. 2024; 15: 790–792. Published online 2024 Nov 12. doi: 10.18632/oncotarget.28671
PMCID:
PMC11559655
ArticlePDF–260K
18.
Retraction: MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4
Dantong Cheng, Senlin Zhao, Huamei Tang, Dongyuan Zhang, Hongcheng Sun, Fudong Yu, Weiliang Jiang, Ben Yue, Jingtao Wang, Meng Zhang, Yang Yu, Xisheng Liu, Xiaofeng Sun, Zongguang Zhou, Xuebin Qin, Xin Zhang, Dongwang Yan, Yugang Wen, Zhihai Peng
Oncotarget. 2024; 15: 767. Published online 2024 Nov 7. doi: 10.18632/oncotarget.28669
Retracts:
Oncotarget. 2016 Jul 19; 7(29): 45199–45213.
PMCID:
PMC11546209
RetractionPDF–207K
19.
A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy
Murtaza Ahmed, Brent K. Larson, Arsen Osipov, Nilofer Azad, Andrew Hendifar
Oncotarget. 2024; 15: 741–747. Published online 2024 Oct 11. doi: 10.18632/oncotarget.28659
PMCID:
PMC11468600
ArticlePDF–1.8M
20.
Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition
Madison Rackear, Elias Quijano, Zaira Ianniello, Daniel A. Colón-Ríos, Adam Krysztofiak, Rashed Abdullah, Yanfeng Liu, Faye A. Rogers, Dale L. Ludwig, Rohini Dwivedi, Franziska Bleichert, Peter M. Glazer
Oncotarget. 2024; 15: 699–713. Published online 2024 Oct 1. doi: 10.18632/oncotarget.28651
PMCID:
PMC11444335
ArticlePDF–4.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center